Ironwood Pharmaceuticals | IRWD - EPS Earnings Per Share


Ironwood Pharmaceuticals reported $0.31 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 0.36 0.24 Oct/29
FY2026Q2 Jun/2026 0.31 0.38 0.14 Aug/06
FY2025Q1 Mar/2026 0.24 0.19 -0.12 May/07




Eps Change Date
Acadia Pharmaceuticals USD 0.18 0.16 Jun/2026
Agios Pharmaceuticals USD -1.69 0 Jun/2026
Akebia Therapeutics USD -0.04 0.04 Dec/2025
Almirall EUR 0.07 0.03 Dec/2025
Alnylam Pharmaceuticals USD 16.26 14.42 Sep/2026
Amarin USD 0.14 0.06 Dec/2025
Ardelyx USD -0.15 0.15 Mar/2026
Astellas Pharma JPY 79.15 54.86 Jun/2026
AstraZeneca USD 2.63 0.05 Jun/2026
Charles River Laboratories USD 3.02 0.96 Jun/2026
Coherus Biosciences USD -0.43 0.06 Dec/2025
Emergent BioSolutions USD -0.77 0.29 Dec/2023
Halozyme Therapeutics USD 2.28 0.68 Jun/2026
Incyte USD -3.6 6.69 Sep/2026
Ironwood Pharmaceuticals USD 0.31 0.07 Jun/2026
Karyopharm Therapeutics USD -1.02 1.2 Mar/2026
Lexicon Pharmaceuticals USD -0.04 0.01 Dec/2025
MacroGenics USD -0.58 0.36 Mar/2026
Moderna USD -1.97 1.43 Jun/2026
Myriad Genetics USD -0.25 0.16 Jun/2026
Pacira USD 0.73 0.13 Jun/2026
PTC Therapeutics USD -0.62 1.54 Sep/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Sarepta Therapeutics USD 0.64 2.52 Jun/2026
Takeda JPY 116.95 45.3 Sep/2026
Ultragenyx Pharmaceutical USD -0.9 0.94 Jun/2026
Vanda Pharmaceuticals USD -0.09 0 Dec/2024